BNET Industries
Last Fiscal Year Sales:$44.3M
- Private
- US
Dow Jones Description
Developer of Cellular Pathway Exploration Tools, Protein Arrays, Antibodies & Recombinant Proteins
Chief Executive Officer
James H. ChamberlainNumber of Employees 239
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
News & Analysis
Filter by
biosource international inc. - All News and Analysis
Genzyme Licenses Exclusive Rights to Chronic Myeloid Leukemia Markers and Invitrogen Closes Acquisition of Biosource International, Inc.
M2 PRESSWIRE-6 October 2005-US Financial Network: Genzyme Licenses Exclusive Rights to Chronic Myeloid Leukemia Markers and Invitrogen Closes Acquisition of Biosource International, Inc.C1994-2005 M2 COMMUNICATIONS LTD RDATE:06102005 City of Industry, CA - Biotechnology industry news provided by Financial News USA...
Invitrogen Acquires Quantum Dot and BioPixels®, Adding Nanotechnology Portfolio to Its Molecular Probes Franchise; Company Also Closes Acquisition of Biosource International, Inc
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a leading life science company providing innovative technologies to support disease research, announced the acquisitions of Quantum Dot Corporation and the BioPixelsR business unit of BioCrystal, Ltd. and the early closing of the Biosource International, Inc. (Nasdaq:BIOI) acquisition.
Invitrogen Corp. to Purchase BioSource International for 2.93 Times Revenue
The Deal: Invitrogen Corporation has signed a definitive merger agreement with BioSource International. Under the terms of the agreement, Invitrogen will purchase BioSource for $12.50 per share in an all-cash transaction. The deal values BioSource at about $130 million for all shares issued and outstanding. The transaction requires approval from...
Invitrogen to acquire BioSource, beating out Bio-Rad
Carlsbad, CA 7/26/05; Camarillo, CA 7/26/05--Invitrogen has signed a definitive agreement to acquire BioSource International for $130 million in cash, or $12.50 per share, a 10% premium over the July 15 closing price. "The acquisition of BioSource enables our company to continue its growth in the vital area of proteomics,"...
Bellwether Report is Following Biosource International Inc.
M2 PRESSWIRE-27 July 2005-bellwetherreport.com: Bellwether Report is Following Biosource International Inc.C1994-2005 M2 COMMUNICATIONS LTD RDATE:27072005 Today the Bellwether Report has identified Biosource International Inc. (Nasdaq:BIOI), a company that our analysts will be tracking over the ensuing weeks. They recently came...
Invitrogen Signs Definitive Agreement to Acquire BioSource International; Deal Strengthens Proteomics Franchise and Positions the Company to Enter New Markets
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced the signing of a definitive agreement to acquire publicly held life sciences company BioSource International (Nasdaq:BIOI) in an all-cash transaction totaling approximately $130 million. The transaction is subject to customary closing conditions, including regulatory approval and the approval of BioSource stockholders. The...
BioSource International, Inc. To Host Conference Call On First Quarter Financial Results
CAMARILLO, Calif. -- BioSource International, Inc. (Nasdaq:BIOI) today announced that it plans to report results for its first quarter ended March 31, 2005 on April 25, 2005 before the opening of the market. The Company will also host an investor conference call to discuss its first quarter financial results...
BioSource Board Unanimously Rejects Bio-Rad Offer
CAMARILLO, Calif. -- BioSource International, Inc. (Nasdaq:BIOI) today announced that its Board of Directors, in a special meeting held earlier today, voted unanimously to reject an unsolicited proposal from Bio-Rad Laboratories, Inc. (Amex:BIO) (Amex:BIOB), dated April 6, 2005, to acquire all of BioSource's outstanding shares at $8.50 per share in...
Bio-Rad Labs Makes Public Offer of 1.86 Times Revenue for BioSource International
The Deal: Bio-Rad Laboratories Inc. has made an unsolicited offer of $8.50 per share in cash for BioSource International Inc. The bid represents a premium of about 21 percent over recent BioSource closing prices and a 30 percent premium over the company's three-year average closing price. Bio-Rad said that it...
BioSource International released the Mercator PhosphoArray multiplex protein array
BioSource International released the Mercator PhosphoArray multiplex protein array, developed with Whatman Schleicher & Schuell.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| James H. Chamberlain | Chief Executive Officer |
| David F. Hoffmeister | Senior Vice President, Chief Financial Officer |
| Karen S Gibson | Senior Vice President, Chief Information Officer |
| Kelli Richard | Vice President, Finance and Chief Accounting Officer |
| Bernd Brust | Senior Vice President, Global Sales |
| Claude D Benchimol | Senior Vice President, Research and Development |
| John A Cottingham | Senior Vice President, General Counsel and Corporate Secretary |
| Kip Miller | Senior Vice President, Biodiscovery |
| Nicolas M Barthelemy | Senior Vice President, Cell Culture Systems |
| Paul D Grossman | Senior Vice President, Strategy and Corporate Development |
| Peter M Leddy | Senior Vice President, Human Resources |
| Amanda Clardy | Vice President, Investor Relations |
| Amy Butler | Invitrogen Vice President of Gene Expression Profiling |
| August Sick | Vice President and General Manager of Invitrogen's Molecular Probes Business |
| Jeff Greenberg | Vice President of Bioproduction |
| Joe Davis | Vice President, Technical Operations |
| Joydeep Goswami | Vice President of Stem Cells and Regenerative Medicine |
| Kevin Reagan | Vice President |
| Kornelija Zgonc | Vice President, Instrumentation and Engineering |
| Paul Predki | Invitrogen Vice President of Research and Development |
| Siddhartha C Kadia | Vice President, Global Marketing and Ebusiness |
| Valerie Bressler-Hill | Vice President, Marketing |
| Todd Laird | General Manager |
| Farnaz Khadem | Director, Corporate Communications |
| James Meegan | Senior Director of Research & Development |
| Eric Endicott | Public Relations Manager |
| Harry Goulding | Manager, IT |
| Lisa Peterson | Manager, Communications |
| Rene Nelson | Manager, Marketing |
| Revelle Anderson | Public Relations Manager |
| Alicia Aldis | Agent, Purchasing |
| Geni Schnitzer | AP Processor |
| Ken Rhodes | Supervisor, Elisa Manufacturing |
| Balakrishnan S. Iyer | Director |
| Jean-Pierre L. Conte | Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Jay M. Short | Executive Director and Chairman, E.O. Wilson Biodiversity Foundation |
| John L. Zabriskie | Board of Directors |
| Ronald A. Matricaria | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Chief Executive Officer | Current |
| Marligen Bioscience, Inc. | Director and Chairman | Current |
| Protea Biosciences, Inc. | Director | Current |
| Wvu Foundation, Inc | Board of Directors | Current |
| Biosource International, Inc. | Director | Current |
| Alpha Innotech Corporation | Director | Current |
| Biosource International, Inc. | President | Former |
| Pepperdine University | MBA Executive Program | Former |
| West Virginia University | Bachelor of Arts Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Microseq | Senior Vice President, Chief Financial Officer | Current |
| Oligoperfect | Chief Financial Officer, Senior Vice President, Finance | Current |
| Molecular Probes | Senior Vice President, Chief Financial Officer | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Chief Financial Officer, Senior Vice President, Finance | Current |
| Bioreliance Corporation | Senior Vice President, Chief Financial Officer | Current |
| Seqanswers | Chief Financial Officer, Senior Vice President, Finance | Current |
| IDEXX Laboratories, Inc. | Senior Vice President, Chief Financial Officer | Current |
| Industry Ventures | Senior Vice President, Chief Financial Officer | Current |
| Resgen Inc. | Senior Vice President, Chief Financial Officer | Current |
| Emiliem, Inc. | Chief Financial Officer, Senior Vice President, Finance | Current |
| Biosource International, Inc. | Senior Vice President, Chief Financial Officer | Current |
| Ionsource, LLC | Senior Vice President, Chief Financial Officer | Current |
| Biolayer Corporation Limited | Senior Vice President, Chief Financial Officer | Current |
| Sorbates | Chairman of the Audit Committee | Current |
| Celanese Chemicals, Inc. | Chairman of the Audit Committee | Current |
| Celvol | Chairman of the Audit Committee | Current |
| Bioreliance Corporation | Board of Directors | Current |
| Vinamul Polymers | Chairman of the Audit Committee | Current |
| Celvol | Member | Current |
| McKinsey & Company, Inc. | Senior Partner | Former |
| Sunett | Chairman of the Audit Committee | Current |
| McKinsey & Company, Inc. | NA | Former |
| GTE | NA | Former |
| Global Finance&Limited | Leader | Former |
| Premiol | Chairman of the Audit Committee | Former |
| At Plastics Inc | Chairman of the Audit Committee | Former |
| Celanese Corporation | Chairman of The Audit Committee | Former |
| Connect Celanese | Chairman of the Audit Committee | Former |
| McKinsey & Company, Inc. | Director | Former |
| University of Chicago | M.B.A. | Former |
| University of Minnesota | B.S. In Business | Former |
Karen S. Gibson has served as Chief Information Officer of Invitrogen since January 2004. Prior to joining Invitrogen she served as Vice President of Global eBusiness and Chief Information Officer (CIO) for General Electric (GE) Medical Systems Information Technologies. From January 1997 to May 2000 Ms. Gibson served as an Information Management Leader within GE's Industrial Systems division. Ms. Gibson has also served as Director of IT for Quantum Health Resources and Ethicon Endo-Surgery, Inc. (a Johnson & Johnson Company). Ms. Gibson received a B.S. in Computer Technology from Purdue University, and an M.B.A. from Ohio University.
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Vice President, Chief Information Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President, Finance and Chief Accounting Officer | Current |
| Bioreliance Corporation | Vice President, Finance and Chief Accounting Officer | Current |
| Biolayer Corporation Limited | Vice President, Finance and Chief Accounting Officer | Current |
| Emiliem, Inc. | Vice President, Finance and Chief Accounting Officer | Current |
| Molecular Probes | Vice President, Finance and Chief Accounting Officer | Current |
| Bioreliance Corporation | Board of Directors | Current |
| The Reporting Company | Former | |
| The University of Iowa | Bachelor of Business Administration Degree | Former |
Bernd Brust has served as Senior Vice President of Sales for Europe and the Americas since November 2006. Brust joined Invitrogen in 2004 and previously served as General Manager and Vice President of European Operations. He has more than 15 years of sales, commercial operations and management experience. Prior to joining Invitrogen he served as General Manager of Sales & Marketing for GE Medical Systems Information Technologies, where he was awarded GE Medical Systems IT Commercial Leader of the Year. Brust holds a degree in Engineering from MTS in Amsterdam and is Six Sigma Green Belt certified.
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Vice President, Global Sales | Current |
Claude D. Benchimol Ph.D. has served as Senior Vice President of Research and Development of Invitrogen since September 2003. Prior to Invitrogen, Dr. Benchimol held a variety of technology leadership roles during his more than 15 years at General Electric (GE) Corporation. He was Vice President and General Manager of global technology for GE Medical Systems Information Technologies, serving in that position from January 2002 to August 2003. Prior to GE Dr. Benchimol was employed by Thomson-CGR, a medical imaging company. He served as Manager of Advanced Research Laboratory from 1981 to 1988 and Research Engineer from 1979 to 1980. Dr. Benchimol received an equivalent of an M.S. in Engineering from cole Nationale Superieure des Telecommunications in France, as well as an M.S. and Ph.D. in Systems Science from the University of California, Los Angeles. Dr. Benchimol is also a member of the French Academy of Technology.
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Vice President, Research and Development | Current |
John Cottingham is Life Technologies' Chief Legal Officer, and served as Invitrogen's Senior Vice President, General Counsel and Secretary since May 2004. He served as Vice President, General Counsel for Invitrogen from September 2000 until May 2004. Prior to the merger of the former Life Technologies, Inc. (LTI) with Invitrogen, Mr. Cottingham was the General Counsel and Assistant Secretary of LTI from January 1996 to September 2000. From May 1988 through December 1995, he served as an international corporate attorney with the Washington, D.C. office of Fulbright and Jaworski L.L.P. Mr. Cottingham received his B.S. in political science from Furman University, his J.D. from the University of South Carolina, his LL.M. in Securities Regulation from Georgetown University and his M.S.E.L. from the University of San Diego. He is a member of the board of directors of the California Healthcare Institute and the San Diego chapter of the Association of Corporate Counsel.
| Organization | Position | Status |
|---|---|---|
| Pittsburgh Tissue Engineering Initiative, Inc | Chief Legal Officer | Current |
| IDEXX Laboratories, Inc. | Chief Legal Officer | Current |
| Microseq | Chief Legal Officer | Current |
| Biolayer Corporation Limited | Chief Legal Officer | Current |
| Ionsource, LLC | Chief Legal Officer | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Senior Vice President, General Counsel and Secretary | Former |
| Molecular Probes | Senior Vice President, General Counsel and Corporate Secretary | Current |
| Emiliem, Inc. | Senior Vice President, General Counsel and Corporate Secretary | Current |
| Bioreliance Corporation | Senior Vice President, General Counsel and Corporate Secretary | Current |
| Seqanswers | Senior Vice President, General Counsel and Secretary | Current |
| Oligoperfect | Senior Vice President, General Counsel and Secretary | Current |
| Biosource International, Inc. | Senior Vice President, General Counsel and Corporate Secretary | Current |
| Resgen Inc. | Senior Vice President | Current |
| Resgen Inc. | General Counsel | Current |
| Resgen Inc. | Board of Directors | Current |
| California Healthcare Institute, Inc. | Board of Directors | Current |
| Biolayer Corporation Limited | Senior Vice President, General Counsel and Corporate Secretary | Former |
| Resgen Inc. | Vice President, General Counsel | Former |
| Fulbright & Jaworski L.L.P. | NA | Former |
| University of San Diego | Masters of Science In Executive Leadership | Former |
| University of South Carolina | J.D. | Former |
| Georgetown University | Ll.M. In Securities Regulation | Former |
| Furman University | B.A. In Political Science | Former |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Vice President, Biodiscovery | Current |
| Organization | Position | Status |
|---|---|---|
| Industry Ventures | President, Cell Systems | Current |
| IDEXX Laboratories, Inc. | President, Cell Systems | Current |
| Resgen Inc. | President, Cell Systems | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Senior Vice President, Cell Systems Division | Former |
| Pittsburgh Tissue Engineering Initiative, Inc | President, Cell Systems | Current |
| Biolayer Corporation Limited | President, Cell Systems | Current |
| Microseq | President, Cell Systems | Current |
| Molecular Probes | Senior Vice President, Cell Culture Systems | Current |
| Biosource International, Inc. | Senior Vice President, Cell Culture Systems | Current |
| Seqanswers | Senior Vice President, Cell Systems Division | Current |
| Emiliem, Inc. | Senior Vice President, Cell Culture Systems | Current |
| Oligoperfect | Senior Vice President, Cell Systems Division | Current |
| Bioreliance Corporation | Board of Directors | Current |
| Biolayer Corporation Limited | Senior Vice President, Cell Culture Systems | Former |
| University of California, Berkeley | M.S. In Chemical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Emiliem, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Industry Ventures | Senior Vice President, Strategy and Corporate Development | Current |
| Bioreliance Corporation | Senior Vice President, Strategy and Corporate Development | Current |
| Microseq | Senior Vice President, Strategy and Corporate Development | Current |
| Biolayer Corporation Limited | Senior Vice President, Strategy and Corporate Development | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Senior Vice President, Strategy and Corporate Development | Current |
| Oligoperfect | Senior Vice President, Strategy and Corporate Development | Current |
| Olink | Senior Vice President, Strategy and Corporate Development | Current |
| IDEXX Laboratories, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Seqanswers | Senior Vice President, Strategy and Corporate Development | Current |
| Ionsource, LLC | Senior Vice President, Strategy and Corporate Development | Current |
| Biosource International, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Molecular Probes | Senior Vice President, Strategy and Corporate Development | Current |
| Resgen Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Applied Biosystems Group | Vice President, Intellectual Property | Current |
| Applied Biosystems Group | Research Associate | Former |
| Santa Clara University | JD | Former |
| University of California, Berkeley | Ph.D. in chemical engineering | Former |
| University of Virginia | master's degree in chemical engineering | Former |
| University of Virginia | B.S. | Former |
| University of California, Berkeley | B.S. | Former |
Peter M. Leddy has served as Invitrogen's Senior Vice President of Human Resources since July 2005. Prior to Invitrogen, Dr. Leddy held several senior management positions with Dell Incorporated from 2000 to 2005 and was most recently, Vice President, Human Resources for Americas Operations. Prior to joining Dell Incorporated, Dr. Leddy served as the Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites). Dr. Leddy also served in a variety of executive and human resource positions at PepsiCo. Dr. Leddy received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. in Industrial/Organizational Psychology from the Illinois Institute of Technology.
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Vice President, Human Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Emiliem, Inc. | Vice President, Investor Relations | Current |
| Ionsource, LLC | Vice President, Investor Relations and Corporate Communications | Current |
| Molecular Probes | Vice President, Investor Relations | Current |
| Seqanswers | Vice President, Investor Relations | Current |
| IDEXX Laboratories, Inc. | Vice President, Investor Relations and Corporate Communications | Current |
| Olink | Vice President, Investor Relations and Corporate Communications | Current |
| Oligoperfect | Vice President, Investor Relations | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Vice President, Investor Relations | Current |
| Microseq | Vice President, Investor Relations and Corporate Communications | Current |
| Bioreliance Corporation | Vice President, Investor Relations | Current |
| Biolayer Corporation Limited | Vice President, Investor Relations | Current |
| Industry Ventures | Vice President, Investor Relations and Corporate Communications | Current |
| Biosource International, Inc. | Vice President, Investor Relations | Current |
| Resgen Inc. | Vice President, Investor Relations and Corporate Communications | Current |
| Resgen Inc. | Board of Directors | Former |
| Purdue University | Masters of Business Administration | Former |
| Fairfield University | Bachelor of Science Degree In Finance | Former |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Invitrogen Vice President of Gene Expression Profiling | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President and General Manager of Invitrogen's Molecular Probes Business | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President of Bioproduction | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President, Technical Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President of Stem Cells and Regenerative Medicine | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President, Instrumentation and Engineering | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Invitrogen Vice President of Research and Development | Current |
Array
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President, Global Marketing and Ebusiness | Current |
| Johns Hopkins University School of Medicine | Former | |
| McKinsey & Company, Inc. | Former | |
| Rutgers University | M.S. In Biomedical Engineering | Former |
| Gujarat University | B.E. In Electronics and Telecommunications Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Vice President, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | General Manager | Current |
| Biosource International, Inc. | General Manager | Former |
| Organization | Position | Status |
|---|---|---|
| Diversa Corporation | Chief Executive Officer | Current |
| Bioatla, LLC | Chief Executive Officer | Current |
| The Eo Wilson Biodiversity Foundation | Founder and Founding President and Chairman | Current |
| Biosource International, Inc. | Executive Director and Chairman, E.O. Wilson Biodiversity Foundation | Current |
| Bioatla, LLC | Founder | Current |
| Biolayer Corporation Limited | Director of Invitrogen | Current |
| Nventa Biopharmaceuticals Corporation | Chair | Former |
| Bioatla, LLC | Executive Chairman | Current |
| Diversa Corporation | Chairman | Current |
| Senomyx, Inc. | Director | Current |
| Bioreliance Corporation | Board of Directors | Current |
| Ciris Energy Inc. | Director | Current |
| Bioatla, LLC | Board of Directors | Current |
| Neurorepair, Inc. | Board of Directors | Current |
| Bioduro Ltd. | Director | Current |
| Senomyx, Inc. | Member | Current |
| Diversa Corporation | President | Former |
| Diversa Corporation | Chief Technology Officer | Former |
| Co-Operations Inc | Vice President of Research and Development | Former |
| The Eo Wilson Biodiversity Foundation | Executive Director | Former |
| Diversa Corporation | Executive Director | Former |
| Diversa Corporation | Director | Former |
| Stressgen Biotechnologies Corporation | Director | Former |
| Case Western Reserve University | Ph.D. In Biochemistry | Former |
| Ohio.Com | PH.D. In Biochemistry | Former |
| Taylor University | BA In Chemistry | Former |
| Diversa Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Director, Corporate Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Senior Director of Research & Development | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Public Relations Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Manager, IT | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Manager, Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Public Relations Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Agent, Purchasing | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | AP Processor | Current |
| Organization | Position | Status |
|---|---|---|
| Biosource International, Inc. | Supervisor, Elisa Manufacturing | Current |
Balakrishnan S. Iyer, age 50 —Mr. Iyer has been a director of Conexant since 2002. He served as senior vice president and chief financial officer of the Company from January 1999 to June 2003. He has served as a consultant to Mindspeed Technologies, Inc. (networking infrastructure semiconductors) from June 2003 through December 2004. Mr. Iyer is currently a director of IHS, Inc., Invitrogen Corporation, Power Integrations, QLogic Corporation and Skyworks Solutions, Inc.
| Organization | Position | Status |
|---|---|---|
| Conexant Systems, Inc. | Board of Directors | Current |
| Skyworks Solutions, Inc. | Director | Current |
| Power Integrations, Inc. | Director | Current |
| Conexant Korea, Ltd. | Director | Current |
| QLogic Corp. | Board of Directors | Current |
| Biolayer Corporation Limited | Director | Current |
| Bioreliance Corporation | Director | Current |
| Molecular Probes | Director | Current |
| Biosource International, Inc. | Director | Current |
| QLogic Corp. | Committee Member | Current |
| Power Integrations, Inc. | Committee Member | Current |
| Agma | Committee Member | Current |
| Conexant Systems, Inc. | Chief Financial Officer | Former |
| VLSI Technology, Inc. | Chief Financial Officer | Former |
| VLSI Technology, Inc. | Senior Vice President | Former |
| Advanced Micro Devices, Inc. | Director of Finance | Former |
| Cypress Semiconductor Corporation | corporate controller | Former |
| Wharton Graduate School of the University of Pennsylvania | M.B.A. In Finance | Former |
| University of California, Berkeley | M.S. In Industrial Engineering | Former |
| Indian Institute of Technology | B.S. In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| PureTech Ventures | Co-Founder, Senior Partner | Current |
| Protein Forest, Inc. | General Partner and Co-Founder of Puretech Ventures | Current |
| Genstar Capital LLC | Strategic Advisory Committee Member | Current |
| Protein Forest, Inc. | Chairman | Current |
| The Convergence Forum | Current | |
| Momenta.Com | Board of Directors | Current |
| Biomira Inc. | Board of Directors | Current |
| Harlan Sprague Dawley Inc. | Director | Current |
| PureTech Ventures | Director | Current |
| Biosource International, Inc. | Board of Directors | Current |
| Genstar Capital LLC | Board of Directors | Current |
| Array BioPharma, Inc. | Board of Directors | Current |
| Cellicon Biotechnologies, Inc. | Board Members | Current |
| Protein Forest, Inc. | Board Members | Current |
| ARCA Discovery, Inc. | Board Members | Current |
| Kellogg Company | Board of Directors | Current |
| MacroChem Corporation | Director | Current |
| Pharmacia & Upjohn | CEO | Former |
| The Upjohn Company | CEO | Former |
| Life Science Products, Inc. | CEO | Former |
| Pharmacia Corporation | Chief Executive Officer | Former |
| Merck Manufacturing Division | President | Former |
| Pharmacia Corporation | President | Former |
| Life Science Products, Inc. | President | Former |
| Pharmacia & Upjohn | President | Former |
| Merck & Co. Inc. | Executive Vice President | Former |
| Pure Tech Incorporated | Former | |
| Life Science Products, Inc. | Chairman | Former |
| The Upjohn Company | Chairman | Former |
| MacroChem Corporation | Chair of Board | Former |
| Momenta Pharmaceuticals, Inc. | Board Members | Former |
| Momenta Pharmaceuticals, Inc. | Founding Investors | Former |
| University of Rochester | Ph.D. in organic chemistry | Former |
| Dartmouth College | AB in chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Bioreliance Corporation | Board of Directors | Current |
| Molecular Probes | Board of Directors | Current |
| Biosource International, Inc. | Board of Directors | Current |
| St. Jude Medical, Inc. | Chief Executive Officer | Former |
| St. Jude Medical, Inc. | President | Former |
| Eli Lilly and Company | Former | |
| Haemonetics Corporation | Chairman | Former |
| St. Jude Medical, Inc. | Chairman | Former |
| VistaCare, Inc. | Board of Directors | Former |
| Haemonetics Corporation | Board of Directors | Former |
| Massachusetts College of Pharmacy and Health Sciences | Bachelors Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Genstar Capital LLC | Managing Director | Current |
| NTC Group | principal | Current |
| Genstar Capital LLC | Chairman | Current |
| North American Energy Partners, Inc. | Chairman | Current |
| Cromedica | Chairman | Current |
| Harlan Sprague Dawley Inc. | Director | Current |
| Propex | Director | Current |
| Propex Fabrics Inc | Director | Current |
| Panolam Industries | Director | Current |
| PRA International Inc. | Board of Directors | Current |
| Altra Industrial Motion, Inc | Board of Directors | Current |
| Nevamar | Board of Directors | Current |
| Panolam Industries International, Inc. | Director | Current |
| Biosource International, Inc. | Member | Current |
| PRA International Inc. | Chair of Board | Current |
| North American Energy Partners, Inc. | Director | Former |
| Harvard Business School | MBA | Former |
| Harvard University | M.B.A. | Former |
| Colgate University | BA | Former |
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS

